Bausch Health Companies Inc. Unrecognized Tax Benefits, Interest on Income Taxes Accrued
Bausch Health Companies Inc. (BHC) had Unrecognized Tax Benefits, Interest on Income Taxes Accrued of $34.00 million as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties › Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued · last filed 2017-05-09
- 2017-03-31: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $34.00M.
- 2016-12-31: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $33.00M.
- 2016-09-30: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $42.00M.
- 2016-06-30: Unrecognized Tax Benefits, Interest on Income Taxes Accrued $40.00M.
| Period end | Unrecognized Tax Benefits, Interest on Income Taxes Accrued |
|---|---|
| 2017-03-31 | $34.00M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $33.00M 10-Q · filed 2017-05-09 |
| 2016-09-30 | $42.00M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $40.00M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $40.00M 10-Q · filed 2016-06-07 |
| 2015-12-31 | $46.00M 10-Q · filed 2016-11-09 |
| 2015-09-30 | $36.00M 10-Q · filed 2015-10-26 |
| 2015-06-30 | $33.00M 10-Q · filed 2015-07-28 |
| 2015-03-31 | $33.00M 10-Q · filed 2016-06-07 |
| 2014-09-30 | $4.00M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $4.30M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $1.30M 10-Q · filed 2014-05-09 |
| 2013-09-30 | $2.00M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $1.00M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $500.00K 10-Q · filed 2013-05-03 |
| 2012-09-30 | $2.20M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $800.00K 10-Q · filed 2012-08-03 |
| 2012-03-31 | $400.00K 10-Q · filed 2012-05-04 |
| 2011-09-30 | $21.60M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $20.70M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |